DEI Recognized by Pasadena Magazine as Top Doctors
Pasadena Magazine recognized Dr. Sadda and Dr. Sadun as Top Doctors in their September/October 2023 issue. View the online flipbook from the publisher using the link below. Read more...Los Angeles Business Journal; 2023 Health Care Leadership Symposium & Awards Finalists
Our Chief Scientific Officer, Deborah Ferrington was recently recognized by the Los Angeles Business Journal. In response to the need for quality mental health care for older adults, Ari D. Kalechstein, Ph.D. and his company, Executive Mental Health (EMH) work to...Trends may shift AMD treatment paradigm With Modern Retina
Modern Retina recently covered our conversation with Ophthalmology Times. There once were no treatment options for age-related macular degeneration (AMD), the leading cause of irreversible blindness in the elderly, but there now are multiple therapies available for...PNAS: Coenzyme Q10 trapping in mitochondrial complex I underlies Leber’s hereditary optic neuropathy
AUTHORS: Jack T. Fuller, III; Steven Barnes; Lorenzo A. Sadun; Pujan Ajmera; Anastassia N. Alexandrova; Alfredo A. Sadun In the genetic disease Leber’s hereditary optic neuropathy, inheritance of a specific, single mitochondrial DNA mutation can produce the sudden...Ophthalmology Times: Cellular evidence of retinal ganglion cell transfection after LHON treatment
Alfredo A. Sadun, MD, PhD, and colleagues conducted an international post-mortem study of human eyes treated with adeno-associated virus (AAV2)-based gene therapy for Leber hereditary optic neuropathy (LHON). The results were reported at the American Academy of...Physicians Weekly: Aqueous Shunts with Extraocular Reservoir for Open-Angle Adult Glaucoma: A Report by the American Academy of Ophthalmology
CONTRIBUTORS: Vikas Chopra, Hana L. Takusagawa, Jullia A. Rosdahl, Arthur J. Sit, Grace M Richter, Yvonne Ou, Stephen J. Kim, Darrell WuDunn To evaluate the recently published literature on the efficacy and safety of the use of aqueous shunts with extraocular...Medika Life: Revolutionizing Retinal Imaging: The Role of Artificial Intelligence
By: Dr. SriniVas R. Sadda AI is poised to be instrumental in the decision-making process for physicians, but ultimately, it cannot replace the human element. Retinal imaging is critical in the field of ophthalmology and provides a trove of information that enables...IOVS: Potential Structural Biomarkers in 3D Images Validated by the First Functional Biomarker for Early Age-Related Macular Degeneration – ALSTAR2 Baseline
AUTHORS: Sohaib Fasih-Ahmad; Ziyuan Wang; Zubin Mishra; Charles Vatanatham; Mark E. Clark; Thomas A. Swain; Christine A. Curcio; Cynthia Owsley; SriniVas R. Sadda; Zhihong Jewel Hu Age-related macular degeneration (AMD) is a leading cause of irreversible central...Healio Q&A: Look for signs of AMD even in those without family history
AUTHORS: Deborah Ferrington, PhD, Sara Kellner, Kate YoungFact checked by: Heather Biele Age-related macular degeneration can occur even in patients without a family history, so clinicians must be aware of early warning signs of the disease, according to Deborah...Ophthalmology Times: Afredo A. Sadun, MD, PhD, discusses research targeting LHON
By: David Hutton Scientists at the Doheny Eye Institute, in collaboration with UCLA chemists, demonstrate how a single gene mutation in an enzyme complex known to produce the energy required by cells causes a sudden, blinding disease. In a recent conversation with...Medika Life: Research Drives AMD Treatments Toward Targeted Therapies
By: Deborah Ferrington PhD Age-related macular degeneration (AMD) is the leading cause of blindness for those 55 years and older. As the population ages — not only in the U.S. but worldwide — there is a greater sense of urgency to discover therapies that can...Vision Monday: Doheny Eye Institute Starts Construction of New Eye Center
By: Vision Monday Staff PASADENA, Calif. — Doheny Eye Institute has announced that construction is underway for the new Doheny Eye Center UCLA location in Pasadena, California. The center will be housed on the first floor of the seven-acre Doheny Eye Institute campus,...LABJ: Women of Influence: Health Care 2024 – Marissa Goldberg
By: Los Angeles Business Journal Staff As CEO of Doheny Eye Institute, Marissa Goldberg has made an indelible mark in vision care throughout the Los Angeles area, and in affiliation with UCLA’s Stein Eye Institute, helps lead Doheny to uphold its mission to further...LABJ: Women of Influence: Health Care 2024 – Deborah Ferrington
By: Los Angeles Business Journal Staff Deborah Ferrington, PhD, is Doheny Eye Institute’s chief scientific officer (CSO) and holds the Stephen J. Ryan – Arnold and Mabel Beckman Foundation Endowed Presidential Chair. Dr. Ferrington’s illustrious career includes more...Modern Retina: More companies release information on upcoming presentations at ARVO 2024
By: Sydney M Crago As the annual ARVO conference draws closer, more companies have released information on presentations related to their pipeline and new data. With less than a week until one of ophthalmology’s biggest conferences of the year, companies and...Modern Retina: ARVO 2024: Functional Microperimetric Correlates of OCT Structural Features in AMD
By: Martin David Harp, David Hutton, Sydney M Crago At the ARVO meeting in Seattle, Washington, the Eye Care Network spoke with Giulia Corradetti, MD about AMD. At this year’s ARVO meeting in Seattle, Washington, Giulia Corradetti, MD, gave a research...Modern Retina: ARVO 2024: Genotype-Specific Differences in Mitochondrial Function
By: Martin David Harp At this year’s ARVO meeting, Deborah A Ferrington, MD, PhD, presented “Genotype-specific differences in mitochondrial function specific to the CFH Y402H risk allele associated with AMD.” Deborah A. Ferrington, PhD:Hi, my name is...HCPLive: ARVO President Srinivas R. Sadda, MD, Visualizes Ophthalmology’s Future
By: Connor Iapoce At the end of ARVO 2024, Srinivas R. Sadda, MD, became the organization’s president for the 2024-2025 year. He spoke to HCPLive about his expectations for the next year in eye care. The 2024 Association for Research in Vision and Ophthalmology...Pasadena Magazine: Women in Business Luncheon 2024
By: Pasadena Magazine A wonderful afternoon celebrating the women in our community. Pasadena Magazine, along with Keck Medicine of USC, hosted its annual Women in Business Luncheon at NOOR on April 10. A networking hour kicked off the event with Eyes Of The Marina,...Eyetube: Imaging AMD: Microperimetry and OCT
MEETING COVERAGE: Association for Research in Vision & OphthalmologyARVO: 2024 Giulia Corradetti, MD, explains the correlation between functional microperimetry and structural OCT features in intermediate AMD. Watch the video...Eyetube: SriniVas R. Sadda, MD, Steps in as ARVO President
MEETING COVERAGE: Association for Research in Vision & OphthalmologyARVO: 2024 SriniVas R. Sadda, MD, discusses his new role as ARVO president and how the organization plans to grow and forge stronger international partnerships. Watch the video...ARVO: SriniVas R. Sadda, MD, FARVO named 2024 – 2025 ARVO President
By: ARVO Rockville, Md. — This month, SriniVas R. Sadda, MD, FARVO, was welcomed as the new 2024 – 2025 president for the Association for Research in Vision and Ophthalmology (ARVO) at its Annual Meeting held recently in Seattle, Wash. Sadda has been a member for more...Medika Life: Key Takeaways from the ARVO 2024 Annual Meeting – the Vision Science Community Gathers
By: SriniVas Sadda MD The Association for Research in Vision and Ophthalmology (ARVO) holds an annual meeting that serves as the main forum for the vision science community to gather, exchange ideas, and present new findings and their potential impacts. It is an...Nature: Accurate Prediction of Disease-Risk Factors From Volumetric Medical Scans by a Deep Vision Model Pre-trained With 2D Scan
By: Oren Avram, Berkin Durmus, Nadav Rakocz, Giulia Corradetti, Ulzee An, Muneeswar G. Nittala, Prerit Terway, Akos Rudas, Zeyuan Johnson Chen, Yu Wakatsuki, Kazutaka Hirabayashi, Swetha Velaga, Liran Tiosano, Federico Corvi, Aditya Verma, Ayesha Karamat, Sophiana...DEI Wins 3 GDUSA Health+Wellness Design Awards
We’re thrilled to announce that our Agency of Record, Lentini Design & Marketing, entered several of our designs in a national graphic design competition through Graphic Design USA (GDUSA). It was GDUSA’s annual Health+Wellness Design Awards, and DEI won out of...Ophthalmology Times Europe: EURETINA 2024: Ultra Widefield OCT and the Benefits of Improved Imaging
By: Hattie Hayes, Martin David Harp Srinivas R. Sadda, MD, spoke about the EURETINA meeting, his presentation on ultra widefield imaging, and the value of the international community of retina clinicians connecting in person at meetings. The interview took place at...touchOPHTHALMOLOGY: Driving Collaboration to Address Future Challenges in Ophthalmology
By: touchOPHTHALMOLOGY, Dr. SriniVas Sadda In this interview, Dr SriniVas Sadda, Director of Artificial Intelligence & Imaging Research at the Doheny Eye Institute, and Professor of Ophthalmology at the University of California – Los Angeles (UCLA) Geffen School...Three Doheny Doctors are LA Times’ Orange County Visionaries 2024
Benjamin Bert, MD, FACSBrian A. Francis, MD, MSHugo Y. Hsu, MD By: LA Times’ Orange County Visionaries 2024 Visionary individuals in the healthcare sector are pushing the boundaries of medical innovation, revolutionizing patient care and advancing life-saving...The Complement Factor H (Y402H) risk polymorphism for age-related macular degeneration affects metabolism and response to oxidative stress in the retinal pigment epithelium
Age-related macular degeneration (AMD), the leading cause of central vision loss…